Maykin Ho is Director of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 21,360 shares of BMRN, which is worth approximately $1.4 Million. The most recent transaction as insider was on May 21, 2024, when has been sold 4,720 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.4K
0% 3M change
28.37% 12M change
Total Value Held $1.4 Million

Maykin Ho Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2024
BUY
Grant, award, or other acquisition
-
4,720 Added 18.1%
21,360 Common Stock
May 23 2023
BUY
Grant, award, or other acquisition
-
4,190 Added 20.12%
16,640 Common Stock
May 24 2022
BUY
Grant, award, or other acquisition
-
4,980 Added 28.57%
12,450 Common Stock
May 25 2021
BUY
Grant, award, or other acquisition
-
5,120 Added 40.67%
7,470 Common Stock
Feb 17 2021
BUY
Grant, award, or other acquisition
-
2,350 Added 50.0%
2,350 Common Stock

Also insider at

AGIO
AGIOS PHARMACEUTICALS, INC. Healthcare
FGEN
FIBROGEN INC Healthcare
NMRA
Neumora Therapeutics, Inc.
MH

Maykin Ho

Director
Novato, CA

Track Institutional and Insider Activities on BMRN

Follow BIOMARIN PHARMACEUTICAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Track Activities on BMRN